India, Air Cargo, and Pharmaceutical Exports: Gateway Investment Meets Global Demand
India remains a major source market for finished dosage forms and APIs. Reports highlight how pharma represents an outsized share of international air export value—and why cold-chain capacity at gateways is tightening.
India’s role as a global supplier of pharmaceuticals—and a growing air cargo origin for time-sensitive movements—is well established in industry analysis. Recent sector reporting notes that pharmaceuticals can account for a very large share of India’s international air cargo export value (commonly cited in the quarter to one-third range in trade press), even when they are not the dominant share of volume.
Gateway and cold-chain pressure
When value concentrates on a few lanes, airport infrastructure and ground handlers face sustained pressure to maintain 2–8°C, frozen, or CRT programmes without gaps. That pressure cascades into forwarder booking behaviour: earlier cut-offs, stricter ULD build standards, and more digital handoffs.
For Southeast Asian shippers
India is both competitor and partner in global supply: many formulation and API flows connect India ↔ ASEAN ↔ EU/US. If your supply chain includes Indian CMO or stability batches routed by air, align batch release timing with cool-chain readiness at the first airport of export.
Compliance overlay
Exports remain subject to national drug regulator requirements, customs classification, and destination GDP expectations. Air speed does not waive documentation.
Sources (external)
- Industry analysis cited in Air Cargo Week — cold chain / India context and related pharma airfreight coverage (interpretation for logistics professionals).
Disclaimer
General information only. Verify all regulatory and licence requirements for your product and corridor with qualified experts.
Frequently asked questions
Is sea freight irrelevant for Indian pharma exports?
No—ocean remains critical for bulk and many finished goods where stability budgets allow. Air dominates short shelf-life, clinical, launch, and temperature-critical movements.
What is the biggest operational risk at origin?
Common failure modes include inadequate pre-conditioning of passive shippers, documentation mismatches at acceptance, and feeder truck gaps before the main air leg.
Should we use CEIV-certified handlers in India?
When available for your routing, CEIV Pharma-certified stations can reduce audit friction. Confirm specific station certification status in the IATA One Source registry where applicable.